Letter to the EditorExtended (alternate day) antipsychotic dosing and dopamine supersensitivity psychosis: A case report
Section snippets
Conflict of interest
All the authors assure that there are no commercial or financial involvements that might present an appearance of a conflict of interest in connection with this article.
Role of contributors
Authors VK and GV designed the study. Author GV and VK managed the clinical assessment, literature search. Author VK wrote the first draft of the manuscript and author GV revised and optimized the manuscript.
Acknowledgements
None.
References (9)
Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment
Schizophr. Res.
(1991)- et al.
Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms
Schizophr. Res.
(2012) - et al.
Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis
J. Clin. Psychopharmacol.
(2013) - et al.
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: results of a 2-year prospective study, including an additional 1-year follow-up
J. Psychopharmacol.
(2016)
There are more references available in the full text version of this article.
Cited by (0)
© 2017 Elsevier B.V. All rights reserved.